LIFCO-B Stock Analysis: Lifco (publ) | ST

Conglomerates | ST, Sweden | Market Cap: 141.715m SEK | 12M Return: -9% | Charts, Fundamentals & Technical Analysis

Dental Equipment, Demolition Robots, Electrical Equipment, Contract Manufacturing
Total Rating 44
Safety 79
Buy Signal -0.80
Conglomerates
Industry Rotation: +4.5
Market Cap: 14.7B
Avg Turnover: 113M
Risk 3d forecast
Volatility24.6%
VaR 5th Pctl4.23%
VaR vs Median4.49%
Reward TTM
Sharpe Ratio-0.42
Rel. Str. IBD24
Rel. Str. Peer Group45
Character TTM
Beta0.740
Beta Downside0.615
Hurst Exponent0.498
Drawdowns 3y
Max DD32.20%
CAGR/Max DD0.47
CAGR/Mean DD1.55
EPS (Earnings per Share) EPS (Earnings per Share) of LIFCO-B over the last years for every Quarter: "2021-06": 1.43, "2021-09": 1.13, "2021-12": 3.1, "2022-03": 1.85, "2022-06": 1.66, "2022-09": 1.46, "2022-12": 1.65, "2023-03": 1.72, "2023-06": 1.91, "2023-09": 1.63, "2023-12": 2, "2024-03": 1.52, "2024-06": 2, "2024-09": 1.64, "2024-12": 2.16, "2025-03": 1.84, "2025-06": 1.93, "2025-09": 2, "2025-12": 2.29, "2026-03": 1.99, "2026-06": 2.26,
EPS CAGR: 7.38%
EPS Trend: 95.5%
Last SUE: -1.40
Qual. Beats: -3
Revenue Revenue of LIFCO-B over the last years for every Quarter: 2021-06: 4501, 2021-09: 4158, 2021-12: 4952, 2022-03: 5022, 2022-06: 5508, 2022-09: 5020, 2022-12: 6002, 2023-03: 5959, 2023-06: 6206, 2023-09: 5850, 2023-12: 6439, 2024-03: 6006, 2024-06: 6725, 2024-09: 6282, 2024-12: 7125, 2025-03: 6933, 2025-06: 6943, 2025-09: 6842, 2025-12: 7534, 2026-03: 7186, 2026-06: 7695,
Rev. CAGR: 7.73%
Rev. Trend: 99.3%
Last SUE: 0.41
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

Confidence

Seasonality 10.5 years of data

Jan +3.2% 0
Feb +2.6% 15
Mar -1.7% 25
Apr +4.1% 36
May -0.6% 0
Jun +2.1% 23
Jul +5.1% 20
Aug -2.3% 50
Sep -3.0% 39
Oct +2.5% 24
Nov +0.7% 8
Dec +2.0% 24

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: LIFCO-B Lifco (publ)

Lifco AB is a Swedish industrial conglomerate that operates across three main segments: dental, demolition and tools, and systems solutions. The company distributes dental equipment and consumables, develops medical record systems, and runs dental laboratories. In its industrial segment, Lifco manufactures demolition robots, forest machines, and crane and excavator attachments for heavy machine, construction, forestry, and process industries. A third grouping covers systems solutions, including machinery for electrical installations and recycling, infrastructure products such as electrification and LED-lighting, contract manufacturing of electronic and metal components, and specialty items ranging from coffee machines to tarpaulin systems for trucks.

Founded in 1946 and headquartered in Enköping, Sweden, Lifco conducts business across Europe, North America, Asia, and Australia. The company is a subsidiary of Carl Bennet AB. As an industrial conglomerate, Lifco follows an acquisition-driven model, adding niche operating businesses with strong market positions and recurring revenue under a decentralized structure.

Headlines to Watch Out For
  • Acquisition pipeline accelerates with multiple niche bolt-ons
  • Dental consumables drive high-margin recurring revenue growth
  • European construction slowdown pressures demolition tools segment demand
Piotroski VR-10 (Strict) 6.0
Net Income: 3.85b TTM > 0 and > 6% of Revenue
FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.78 > 1.0
NWC/Revenue: -2.38% < 20% (prev -5.89%; Δ 3.52% < -1%)
CFO/TA 0.12 > 3% & CFO 5.23b > Net Income 3.85b
Net Debt (11.9b) to EBITDA (7.37b): 1.61 < 3
Current Ratio: 0.94 > 1.5 & < 3
Outstanding Shares: last quarter (454.2m) vs 12m ago -0.17% < -2%
Gross Margin: 44.13% > 18% (prev 43.91%; Δ 0.22% > 0.5%)
Asset Turnover: 69.90% > 50% (prev 68.14%; Δ 1.76% > 0%)
Interest Coverage Ratio: 14.32 > 6 (EBIT TTM 5.43b / Interest Expense TTM 379.0m)
Altman Z'' 3.11
A: -0.02 (Total Current Assets 11.8b - Total Current Liabilities 12.4b) / Total Assets 43.7b
B: 0.44 (Retained Earnings 19.0b / Total Assets 43.7b)
C: 0.13 (EBIT TTM 5.43b / Avg Total Assets 41.9b)
D: 0.88 (Book Value of Equity 20.3b / Total Liabilities 23.2b)
Altman-Z'' = 3.11 = A
Beneish M -2.93
DSRI: 1.06 (Receivables 5.65b/4.96b, Revenue 29.3b/27.3b)
GMI: 1.00 (GM 43.91% / 44.13%)
AQI: 0.99 (AQ_t 0.65 / AQ_t-1 0.66)
SGI: 1.07 (Revenue 29.3b / 27.3b)
TATA: -0.03 (NI 3.85b - CFO 5.23b) / TA 43.7b)
Beneish M = -2.93 (Cap -4..+1) = A
What is the price of LIFCO-B shares?

As of July 29, 2026, the stock is trading at SEK 315.20 with a total of 226,040 shares traded. Over the past week, the price has changed by -1.56%, over one month by -0.19%, over three months by +6.20% and over the past year by -9.04%.

Current recommended Stop Loss: 302.80 (which is 3.9% or 1.5 ATR below the current price).

Is LIFCO-B a buy, sell or hold?

Lifco (publ) has no consensus analysts rating.

Lifco (publ) (LIFCO-B) - Fundamental Data Overview as of 25 July 2026
Market Cap USD = 14.7b (142b SEK * 0.1034 SEK.USD)
P/E Trailing = 36.7925
P/E Forward = 35.5872
P/S = 4.8438
P/B = 7.0429
Revenue TTM = 29.3b SEK
EBIT TTM = 5.43b SEK
EBITDA TTM = 7.37b SEK
Long Term Debt = 5.38b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 6.71b SEK (from shortTermDebt, last quarter)
Debt = 13.2b SEK (from shortLongTermDebtTotal, last quarter) + Leases 1.32b
Net Debt = 11.9b SEK (calculated: Debt 13.2b - CCE 1.34b)
Enterprise Value = 154b SEK (142b + Debt 13.2b - CCE 1.34b)
Interest Coverage Ratio = 14.32 (Ebit TTM 5.43b / Interest Expense TTM 379.0m)
EV/FCF = 31.93x (Enterprise Value 154b / FCF TTM 4.81b)
FCF Yield = 3.13% (FCF TTM 4.81b / Enterprise Value 154b)
FCF Margin = 16.44% (FCF TTM 4.81b / Revenue TTM 29.3b)
Net Margin = 13.17% (Net Income TTM 3.85b / Revenue TTM 29.3b)
Gross Margin = 44.13% ((Revenue TTM 29.3b - Cost of Revenue TTM 16.3b) / Revenue TTM)
Gross Margin QoQ = 44.60% (prev 44.41%)
Tobins Q-Ratio = 3.52 (Enterprise Value 154b / Total Assets 43.7b)
Interest Expense / Debt = 2.87% (Interest Expense 379.0m / Debt 13.2b)
Taxrate = 23.02% (1.16b / 5.05b)
NOPAT = 4.18b (EBIT 5.43b * (1 - 23.02%))
Current Ratio = 0.94 (Total Current Assets 11.8b / Total Current Liabilities 12.4b)
Debt / Equity = 0.65 (Debt 13.2b / totalStockholderEquity, last quarter 20.3b)
Debt / EBITDA = 1.61 (Net Debt 11.9b / EBITDA 7.37b)
Debt / FCF = 2.47 (Net Debt 11.9b / FCF TTM 4.81b)
Total Stockholder Equity = 19.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.21% (Net Income 3.85b / Total Assets 43.7b)
RoE = 19.63% (Net Income TTM 3.85b / Total Stockholder Equity 19.6b)
RoCE = 21.71% (EBIT 5.43b / Capital Employed (Equity 19.6b + L.T.Debt 5.38b))
RoIC = 11.42% (NOPAT 4.18b / Invested Capital 36.6b)
WACC = 8.04% (E(142b)/V(155b) * Re(8.58%) + D(13.2b)/V(155b) * Rd(2.87%) * (1-Tc(0.23)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 23.03 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈4.53b ; Y1≈5.19b ; Y5≈7.63b
[DCF] Fair Price = 243.1 (EV 115b - Net Debt 11.9b = Equity 103b / Shares 423.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.53 | EPS CAGR: 7.38% | SUE: -1.40 | # QB: -3
Revenue Correlation: 99.32 | Revenue CAGR: 7.73% | SUE: 0.41 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.48 | Chg30d=+5.98% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=9.95 | Chg30d=-0.69% | Revisions=+40% | GrowthEPS=+23.2% | GrowthRev=+7.9%
EPS next Year (2027-12-31): EPS=11.03 | Chg30d=+1.26% | Revisions=+0% | GrowthEPS=+10.8% | GrowthRev=+6.9%
[Analyst] Revisions Ratio: +38% (up=4, down=1)